Clinical Trials
6 trialsNCT04276376 2025-12-01
ARIANES
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Terminated
NCT02986100 2023-06-09
AME
pharmaand GmbH
Phase 1 Completed
NCT03499444 2023-06-09
A Study of Rucaparib in Japanese Patients With a Previously-treated Solid Tumor
pharmaand GmbH
Phase 1 Completed
NCT01009190 2023-06-08
A Study Of Poly (ADP-Ribose) Polymerase Inhibitor PF-01367338 In Combination With Several Chemotherapeutic Regimens
pharmaand GmbH
Phase 1 Completed
NCT03654833 2023-03-14
MiST
University of Leicester
Phase 2 Unknown
NCT03318445 2021-03-04
Rucaparib and Irinotecan in Cancers With Mutations in DNA Repair
University of California, San Francisco
Phase 1 Completed